A high resolution ion mobility time-of-flight mass spectrometer with electrospray ionization source (ESI-IM-MS) was evaluated as an analytical method for rapid analysis of complex biological samples such as human blood metabolome was investigated. The hybrid instrument (IM-MS) provided an average ion mobility resolving power of ~90 and a mass resolution of ~1500 (at m/z 100). A few µL of whole blood was extracted with methanol, centrifuged and infused into the IM-MS via an electrospray ionization source. Upon IM-MS profiling of the human blood metabolome approximately 1,100 metabolite ions were detected and 300 isomeric metabolites separated in short analyses time (30 minutes). Estimated concentration of the metabolites ranged from the low micromolar to the low nanomolar level. Various classes of metabolites (amino acids, organic acids, fatty acids, carbohydrates, purines and pyrimidines etc) were found to form characteristic mobility-mass correlation curves (MMCC) that aided in metabolite identification. Peaks corresponding to various sterol derivatives, estrogen derivatives, phosphocholines, prostaglandins, and cholesterol derivatives detected in the blood extract were found to occupy characteristic two dimensional IM-MS space. Low abundance metabolite peaks that can be lost in MS random noise were resolved from noise peaks by differentiation in mobility space. In addition, the peak capacity of MS increased six fold by coupling IMS prior to MS analysis.
Introduction

Metabolomics
A parallel branch of biological science to proteomics, genomics, and transcriptomics that deals with the "omics" of metabolites and metabolism is called "metabolomics". Metabolites are small molecular weight compounds (< ~1000 Da) that are employed as building blocks or produced as end products in various metabolic pathways and cellular regulatory processes in a biological system (1, 2) . The entire collection of metabolites in a biological system, whether at the cellular, pathway or organism level, is known as a "metabolome". Levels of these metabolites in a metabolome are either dictated by the genome, proteome, and/or transcriptome of the biological system or imposed by environmental perturbations and results in changes in phenotype (3) (4) (5) . Thus metabolomics can be applied to map or identify the cause of alteration in phenotype and understand correlations between "omics"(6).
Blood analysis
Determination of metabolites present in blood samples provide insight into many human disease mechanisms and identify biomarkers for disease diagnosis (7) (8) (9) (10) . For example, metabolic profiling of amino acids and acylcarnitines is a powerful diagnostic tool in the diagnosis of inborn errors of metabolism (IEM's) such as phenylketonuria PKU, mediumchain acyl-CoA dehydrogenase deficiency MCAD; glutaric acidemia GA, multiple carboxylase deficiency MCD, isovaleric acidemia IVA and other inherent metabolic disorders IMD's (11, 12) . Similarly, monitoring of various metabolic biomarkers present in blood is utilized for diagnosis for several diseases. Multiple sclerosis (13) , HIV-1 (14) , rotavirus gastroenteritis patients (15) , influenza-associated encephalopathy (16) , cystic fibrosis (17, 18) , congenital adrenal hyperplasia CAH (19) , antley-bixler syndrome ABS and apparent pregnene hydroxylation deficiency APHD (20) , gaucher type 3 disease (21), cancer (22) , fabry's disease, glycolipid lipidosis (23) , atherosclerosis (24) , blood-circulation disorders (25) , acute hepatitis (26) , anemia and glucose-6-phosphatase deficiency (27) are some of the diseases where metabolite(s) monitoring is applied for diagnostic/screening purposes.
Current analytical methods
Different metabolite analysis strategies can be applied to characterize a metabolome, such as 1) Metabolite target analysis, 2) Metabolite profiling, 3) Metabolomics, 4) Metabolic fingerprinting, 5) Metabonomics, and 6) Metabolic footprinting (10, (28) (29) (30) . However, lack of efficient instrumental analytical techniques that can rapidly analyze complex biological samples and can provide sufficient visualization of the metabolome with diverse chemical and physical nature of metabolites require an array of analytical techniques for comprehensive analysis of a metabolome. Selection of the most suitable technique generally requires a compromise among speed, selectivity and sensitivity. Analytical separation methods such as gas chromatography (31) (32) (33) (34) , high-performance liquid chromatography (35) (36) (37) (38) (39) (40) (41) , capillary electrophoresis (42) (43) (44) (45) , and ion-exchange chromatography (46) in tandem with mass spectrometry have been investigated for their application to metabolomics. Spectroscopic methods such as NMR have also been extensively explored for metabolomics studies (47) (48) (49) (50) . Examples include application of NMR to assess effects of chemical, physical, and biological stressors on organisms (51, 52) . Currently, NMR, GC, HPLC, and CE are extensively used in metabolic profiling and targeted metabolite analysis for disease diagnosis and treatment, detection and identification of biomarkers and drug synthesis and metabolism investigations (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) (64) (65) (66) (67) (68) .
In general, however, all of these methods require labor intensive and time consuming sample preparation (extraction, derivatization, concentration, etc.) and are mostly suited for analysis of a specific class of metabolites. Thus, there is a need for innovative approaches for measuring, monitoring and identifying the metabolome (69, 70) . Techniques that would allow rapid and simultaneous determination of several classes of metabolites would not only increase sample throughput but would also make profiling of metabolome possible under different stress conditions, and understanding relative variation of metabolites or metabolite classes under a specific stress condition. Such an analytical tool would enable identification of more biomarker(s) for confirmation of diseases.
Ion mobility spectrometry coupled with mass spectrometry (IM-MS) is a rapid two dimensional analytical tool and has been applied to various biological (71) (72) (73) , pharmaceutical (74) (75) (76) (77) (78) , environmental (79) (80) (81) (82) and security related applications (83) (84) (85) . Feasibility of using IM-MS as a rapid analytical tool for metabolome profiling has been recently demonstrated where rapid separation and detection of hundreds of metabolites present in intracellular E-coli metabolome along with simultaneous separation of isomeric and isobaric metabolites was achieved (86) . This manuscript evaluates the potential of IM-MS for application to blood metabolome profiling.
Experimental
Chemicals and Sample preparation
High performance liquid chromatography grade solvents (methanol, water and acetic acid) were purchased from J. T. Baker (Phillips burgh, NJ). Blood samples were collected anonymously from the finger tips of the donor. The finger tips were first cleaned with sterilizing alcohol and then pierced with sterilized Glucose meter lancets (OneTouch UltraSoft) purchased from local departmental store (Rite Aid, Pullman, WA). Blood drops from finger tips were directly collected into methanol as extraction solvent. Approximately 50 µL of blood was added to 950 µL of methanol and acetic acid (1%) solution maintained at 40°C over a heated water bath. The hot methanol-acetic acid-blood solution was kept in 40°C water bath for 30 minutes and then centrifuged for 1 hour at 1500 revolutions per minute. The supernatant was subjected to analysis by ESI-IM-MS without further sample preparation.
Instrumentation
The ESI-IM-MS instrument; schematic and picture shown in Figure 1 ; was comprised of an electrospray ionization source, an ion mobility spectrometer operated at ambient pressure and a time-of-flight mass spectrometer.
2.2.1
Electrospray source-For electrospray ionization, samples were infused into a 15 cm long, 50µm inner diameter silica capillary transfer line by a KD Scientific 210 syringe pump (New Hope, PA) at a flow rate of 4µl/min. The capillary transfer line was connected to a 10 cm long 50µm inner diameter silica capillary through a stainless steel junction. A positive voltage of 15.12 kV was applied at the stainless steel junction to generate the electrospray. This 10cm long capillary served as the electrospray needle and was centered 0.5cm from a target screen in the IMS.
2.2.2
Ion mobility spectrometer-A stacked-ring design ion mobility spectrometer used in this study was constructed at Washington State University as described in previous publications (87, 88) . The APIMS tube was divided by a Bradbury-Nielsen ion gate into a 7.5 cm long desolvation region and a 17.3 cm long drift region. Both regions consisted of alternating alumina spacers and stainless steel rings with high temperature resistors connecting the stainless steel rings (500 kΩ resisters for the desolvation region, 1MΩ resisters for the drift region). The ion gate was held at an electrical potential of 9934 volts; with last ring of IMS at 285 V. Thus, the electric field was ~558 V/cm throughout the drift region. Using the Bradbury-Nielsen gate, ions were pulsed into the drift region with a pulse width of 0.2 milliseconds. The temperature inside the IMS tube measured at the center of the desolvation region was 179°C. Nitrogen was used as the drift gas at a flow rate of 1100 ml/ min. During these studies the atmospheric pressure in Pullman, WA, was 703-705 Torr. The ESI source, the ion mobility spectrometer, and supporting electronics were designed and assembled at Washington State University, Pullman.
Pressure interface-
To couple an ambient pressure IMS system to a low pressure time-of-flight mass spectrometer, a interface was constructed at Ionwerks Inc., Houston, TX. The interface consisted of three ion lenses (nozzle, focusing, and skimmer) enclosed in a stainless steel chamber. The voltages applied on each element were: nozzle + 74 V, focusing lens +62V, skimmer + 35 V. These setting provided optimum ion transmission through the interface with minimum ion fragmentation at the interface. However, any variation in the position of the IMS and/or voltage on the last IMS electrode would require optimization of the lens voltages. Ions exiting the IMS entered a differentially pumped chamber through a 250 µM aperture in the nozzle and entered the ion beam region of the MS through a 250 µM aperture in the skimmer. 
Time
Pressure considerations and
Data acquisition-Pressure in the interface (1.5 torr), ion beam region (2×10 −2 torr) and reflectron region (1.4×10 −6 torr) was maintained using two Varian rough pumps (100 L/min DS102 and 600 L/min DS602) and two Varian turbo pumps (68 L/s-V70 and 250 L/s-V250). The IMS and the MS were scanned at 25 Hz and 25 kHz respectively. Typical timing sequence and data acquisition has been described previously (89) . The two dimensional IM-MS data was displayed as contour plots using IDL Virtual machine based software developed by Ionwerks Inc.
Basic IMS theory and calculations
Ion mobility spectrometry separates ions on the basis of the differences in their mobility K (cm 2 V −1 s −1 ) while the ions are drifting through a drift gas in a weak homogenous electric field gradient. The mobility of an ion through the drift region of the ion mobility tube is given as the ratio of the average ion velocity
where, L is the length of the drift region in cm, t d is the drift time in seconds (defined as the time an ion takes to travel through the drift region), and V is the voltage applied to the ion gate in volts. Experimental results are reported in terms of ion mobility reduced to standard temperature and pressure defined as:
Separation of ionic species in IMS is achieved due to the differences in the collision cross sections of the ions. Equation 3 defines the average ion-neutral collision cross section (Ω) measured in Å 2 in terms of measured mobility of the ion: (90) (3) where, N A is the number density of the drift gas in molecules per cm 3 , µ [=mM/(m+M)] is the reduced mass in kilograms of an ion of mass m g/mol and the neutral drift gas of M g/ mol, k is Boltzmann's constant in J/K, z is the number of the charge(s) on the ion, e is the charge of one proton in coulombs and K is the mobility of the ion in cm 2 V −1 s −1 . Number density N A is calculated as N A = (P/ k T) where P is the atmospheric pressure in atmospheres, k is the Boltzmann's constant in L*atm. / K and T is the temperature in Kelvin.
Results and Discussion
Resolving power, sensitivity, reproducibility, and dynamic range
The mass range of the time-of flight mass spectrometer was calibrated through ESI-IM-MS analysis of 2,4-lutidine (m/z 107.2) and stachyose (m/z 666.6). Stachyose was detected as a sodium adduct (M + Na) + and 2,4-lutidine as a protonated monomer (M + H) + . Average MS resolving power; measured using the equation R = m/Δm, where m is the mass of the peak and Δm is the full width at half maximum (FWHM), was 1500. Average resolving power of IMS defined as the ratio of the drift time of the ion to the peak width (in time) at half height (R p = t d /w h ) was measured to be 90. Reduced mobility value measured for 2, 4-lutidine (m/z of 108) was 1.96 ± .01 cm 2 V −1 s −1 (literature value = 1.95). Average resolving power of first generation IM-MS constructed previously in our laboratory was 700 for the MS and 60 for the IMS(89).
To determine the reproducibility, detection limit, and dynamic range of IM-MS measurement, mixture solutions containing eleven metabolites (serine, nicotinamide, adenine, lysine, glutamine, ribose, phenylalanine, arginine, glucose, lactose, and maltose) each at 1 mM, 50 uM, and 500 nM concentrations prepared in 50:50 MeOH-H 2 O with 1% acetic acid were analyzed by ESI-IM-MS. Interface Definition Language (IDL) files developed by IonWerks Inc. Houston, and executed using IDL virtual machine platform (IDL VM 6.2, ITT Visual Information Solutions, Boulder, CO) were used for data processing and visualization. In an unprocessed IM-MS spectrum the whole 2D IM-MS space is filled with noise and analyte signals as shown in Figure 2S frame d (see supporting information). Adjustment of ion count threshold and averaging is employed to filter out noise peaks from the raw spectrum and the processed spectrum as shown in Figure 4a is obtained. Due to variation in instrumental and chemical noise signals from one data set to another the magnitude of threshold and averaging adapted to visualize a noise free spectrum varies from one data set to another. At present due to lack of an automatic noise recognition and removal tool "stare and compare strategy" was employed during noise removal. Theoretically, even one ion count above the noise level should be considered as an analyte signal. However, a simple curve (peak in this case) as defined by second degree polynomial equation (y = ax 2 + bx + c) will need three points, peaks with less than three ion counts were discarded. For reference, zoomed in IM-MS spectra showing IM-MS signals with 3, 5 and 45 ions counts for known analytes are also shown in frames a, b, and c in Figure 2S (supporting information). During presentation of some examples further in the text, the threshold was increased higher than needed to exclude noise signals just to reduce clutter of peaks in the IM-MS spectrum and or to minimize labor intensive statistical data processing and metabolite identification. Low abundance metabolite peaks were thus not accounted for in the examples. An IM-MS spectrum for a 500 nM mixture solution of eleven metabolites is shown in Figure 2 . On the x-axis is shown the mass-to-charge ratio of the ions in Da and the y-axis represents the IMS drift time of ions in microseconds. All of the metabolites in the mixture were detected and identified as one or more than one of the following adduct ions {M (H 2 O) n + Na} + , {M (H 2 O) n + H} + , and {M (CH 3 OH) n + H} + (Table 1) . Despite the fact that all metabolites were present in equimolar quantities in the mixture solution (500 nM), the number of ion counts for each metabolite peak ranged between 3 to ~100 counts. This variation in ion count with metabolite identity can be attributed to different ionization efficiencies of metabolites.
Various isomeric/isobaric ions (see Affects of charge competition and ion suppression was also evident upon analysis of equimolar mixtures of metabolites at varying concentrations. For example, peaks for lysine, adenine and nicotinamide were of highest intensity in the 500 nM mixture whereas in 1 mM and 50 µM metabolite mixture, the peak intensities for arginine and ribose were the strongest. Preferential ionization of an analyte was also evident. For example ribose as (M + H 3 O) + ion at m/z 169 Da was observed at 5% intensity of the respective sodium adduct. 2D IM-MS plots for ribose detected with 5 and 45 ion counts as adducts of hydronium ion and sodium ion respectively are shown in frames b, and c in Figure 2S (supporting information).
Calibration curve for ribose as (M + Na) + at m/z value of 173 Da showed a linear relationship between peak intensity and concentration with a slope of 0.2 in the concentration range studied (1 mM to 500 nM). Linear but functional, not proportional, dependence of peak intensity on metabolite concentration was measured. Figure 4a illustrates a 2D IM-MS spectrum of the metabolite ions detected in hot methanol blood extract. On the x-axis is the mass-tocharge ratio of the ions in Da and the y-axis reports the IMS drift times of the ions in microseconds. The IM-MS spectra showed several high intensity metabolite and low intensity metabolite regions with ion counts for the peaks ranging between 3 and ~80. Extent of metabolite recovery in methanol, metabolite abundance in blood, number of isomers and isobars for each metabolite and/or variation in ionization efficiency of metabolites contributes to variation in peak intensities of ions. Not all detected ions are visible in Figure  4a due to relative ion-intensity differences. To visualize low abundance ions, the data file was processed in increments of 100 Da mass range as shown in Figure 4b and signal threshold raised to exclude instrumental noise (dark counts) signals. A list of metabolites detected from the blood extract was generated with each peak characterized by its unique m/ z value, drift time and intensity. Approximately ~1100 metabolite peaks with ion counts ≥ 3 and ~850 metabolite peaks with ion counts ≥ 5 were detected.
Blood Analysis
IM-MS Spectrum-ESI-IM-MS
In an MS-only analysis, analyte peaks are characterized by their m/z values and their intensities. This is also true for the noise peaks. However in an IM-MS analysis the random noise peaks are not associated with unique mobility (drift time) values but instead are spread out in the mobility space in contrast to analyte peaks that are characterized by unique mobility values. Figure 5 illustrates three different conditions when mobility measurements provide added advantages to MS analysis. (2) illustrates an example where in the absence of mobility differentiation a noise peak can be considered to be an analyte peak. Similarly peaks shown with dotted line arrows illustrate an example when an analyte peak can be misinterpreted as noise peak. Contribution of noise peak intensity to the observed intensity of analyte peak is depicted through peaks shown with dashed line arrows in Figure 5 . Approximately four fold decrease in peak intensity at m/z value of 237.4 relative to intensity of peak at m/z value of 265.4 was observed when contribution from noise peak intensity was considered. Figure 6S and Table 2S (see supporting information) lists the metabolites detected with ≥ 5 ion counts along with their tentative identification. Identity of amino acids, pentose sugars and hexose sugars detected in blood extract were validated by comparing the m/z values and reduced mobility values of peaks detected in the blood extract to that measured for standard solutions using ESI-IM-MS. Following sections discuss selected classes of metabolites detected (validated and tentative).
Metabolite Identification
Mobility-Mass-Correlation Curves:
Separation of various classes of compounds such as lipids and peptides based on characteristic mobility-mass-correlation curve (MMCC) formed in two dimensional IM-MS space has been shown (98) . MMCC can provide a valuable tool in the identification of peaks detected in an IM-MS analysis of complex samples. Figure 7 shows the different MMCCs observed for the various classes of metabolites detected in the blood extract by IM-MS. Table 1 . A maximum error of 2% was observed between the K o values of amino acids detected in the blood extract and that of the standards. A deviation of 2% in K o value is also generally observed in day-to-day IMS measurements.
Various isomers of monosaccharides were also detected and identification established. Sugars preferentially form sodium adducts upon ionization by ESI but are also detected in low abundance as adduct ions with proton, hydronium ion, protonated methanol, and potassium(99,100). Pentose sugars were detected at m/z values of 151 (pentose + proton), 165 (methyl pentose + proton), 169 (pentose + hydronium ion), and 173 (pentose + sodim ion). Hexose sugars were detected at m/z values of 181 (hexose + proton), 195 (methylhexose + proton), 203 (hexose + sodium) and 219 (hexose + potassium). Similar to that of amino acids, isomeric sugars were distributed along a MMCC. Due to the isomeric nature of sugars, the sugar isomers were distributed in ~1 ms mobility space along the MMCC whereas the amino acids were confined in <0. Detection and confirmed identification of amino acids and sugars in the blood extract, demonstrate the strength of IM-MS for rapid analysis of complex biological samples to monitor targeted or comprehensive metabolites in the metabolome. Detection of free amino acids present in 50 µL of blood sample using IM-MS without any pre-concentration step demonstrate the potential of IM-MS to detect metabolites such as amino acids that are present in sub-micromolar concentration levels and usually require pre-concentration prior to analysis by chromatographic methods (101) . Because drift times of ions increase with size of the ions, MMCC also provide information on the structure of ions in addition to serving as a visual aide for identification of metabolites in a complex spectrum. For example, in the 2D IM-MS space the amines occupied IM-MS space towards the longer drift times while the unsaturated fatty acids occupied the 2D space towards the shorter drift time relative to amino acid-carbohydrate MMCC ( Figure 6S, A) . This suggests that amines form less compact ions whereas the unsaturated fatty acids tend to form more compact ions upon ionization by ESI, relative to amino acids and monosaccharides. Similarly, in the m/z range of 380 -600 Da ( Figure 6S , B) sterols, diacylglycerophosphocholines, and sphingolipids were detected in the drift time range of 17 to 25 ms whereas the monoacyl glycerophosphocholines and isoprenoids occupied the 2D space in the drift time range of 15-18 ms. Sterols and their derivatives such as stigmasterol, dihydrocholesterol, dihydroxy lanosterol, cholestane-triol have structures that constitute multiple 5 or 6 membered rings with a short hydrocarbon chain, that could prevent folding of the molecule upon ionization. Diacyl glycerophosphocholines, with two hydrocarbon chains, formed less compact ions (drift time range of 17 to 25 ms) compared to the monoacylglycerophosphocholines and isoprenoids (drift time range of 15-18 ms).
Review of the structures of sphingolipids and endogeneous blood isoprenoids such as carotenoids and retinyl oleate (22, 102) , showed that the structures of sphingolipids are less favorable to folding due to two fatty acid tails and usually modified heads when compared to the structures of the isoprenoids that are in general single chain hydrocarbon derivatives. N- MMCC for estrogen derivatives and prostaglandins (lipid biosynthesis/metabolism mediators) are also shown in Figure 7B . Eicosanoids such as prostaglandins are biochemically synthesized from the arachidonic acid and are found in almost all tissues in the human body affecting many essential physiological functions such as contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation (103) . Relative distribution of these metabolites serve as indicators of affects of regulatory mechanisms on specific metabolic pathways and thus ability to separate isomeric forms, detect, and monitor them simultaneously becomes important (104) . Examples of estrogen derivatives detected (circled in the Figure 6S Figure 6S , F) shows that there are two potential sites for methylation (A and B) which may result in two isomeric structures.
3.2.3
Isomer separation-Diversity in lipid and carbohydrate structures and existence of each in various isomeric forms render lipid and carbohydrate profiling a very complicated and difficult task (108) . The most important contribution of ion mobility spectrometry in an IM-MS experiment is the separation of isomeric molecules simultaneous to detection by mass spectrometry. 
Peak capacity of IM-MS-With tandem separation techniques such as IM-MS, CE-MS, LC-MS
, maximum number of peaks that can fit in a two dimensional space is defined as the peak capacity (φ) of the tandem method (109) . Thus peak capacity is a measure of the separation potential of the technique and depends on the resolution of the individual systems and difference in their separation mechanism (orthogonality). A 2D separation technique will have very high φ value if the fundamental separation mechanisms of individual high resolution systems are completely different such as in LC-MS (110, 111) . The peak capacity will also be defined by the complexity of the sample and the physical and chemical properties of the analytes in the sample. For example complex biological samples such as protein/peptide mixtures or metabolomes containing large number of analytes with varying chemical nature would provide larger peak capacities for the technique than that would be through analysis of a mixture of analytes of a specific class. For example the peak capacity of LC-MS, where LC separations occur due to differences in partition coefficient of analyte ions between mobile phase and stationary phase and MS separation is based on their m/z ratios, is quite high due to completely different mechanism of separations involved in the individual analytical method (112) . With IM-MS as a tandem technique where separation occurs due to the differences in the Ω/z values (ion mobility) and m/z values (mass spectrometry), the plot of Ω/z versus m/z generally follow linear trend and thus exhibit smaller φ than LC-MS. With MS resolution of 400, IMS resolution of 60, and a maximum deviation of 11% in drift time, 1 to 5 fold increases in the peak capacity of the IM-MS method has been reported for a mixture of tryptic peptides (m/z range 500-2500). Though peak capacities of upto 10 7 can be achieved for LC-MS upon analysis of protein/peptide mixtures (113, 114) , number of metabolites detected in blood under single experimental condition has been reported to be between ~1000-3000 using LC-MS method (115) (116) (117) . However, even with limited orthogonality in separation, the high resolving power of IMS allowed separation of ~1100 metabolic features in a single experiment using the IM-MS method which is comparable to the number of metabolic features detected by LC-MS (~10 3 ). In addition, because ion mobility is a post-ionization gas phase separation method, temporal separation occurs in milliseconds resulting in very high peak production rate (φs −1 ). IM-MS as compared to LC-MS has at least three orders of magnitude greater φs −1 than LC-MS. An estimation of the peak capacity in IM-MS can be calculated as follows:
Where, R̄I MS is the average resolving power of the ion mobility spectrometer, and R̄M S is the average resolution of the mass spectrometer in an m/z range. For example, in the mass range of 23-830 Da for the metabolites detected the minimum and maximum deviation in drift time along a vertical plane parallel to the y-axis defines the fraction of orthogonality as shown by double sided arrows in Figure 9 . The theoretical MMCC shown as dotted line in the figure is the centre line of the shaded area along which a constant drift time deviation should be observed whereas the MMCC obtained for the experimental data is depicted as bold line in Figure 9 . (Figure 9 , shaded space in the X-Y quadrant). This gives an average deviation in drift time of ± 14% along the theoretical trend. With average IMS resolving power of 90, average MS resolution of 1500, and ± 14 % deviation, the estimated peak capacity for the instrument was ~18900. With MS resolution of 1500, peak width at m/z 404 is 0.27 Da (for the m/z range of 23-830 Da the average m/z value is equal to 404 Da) the estimated peak capacity of MS alone was 2989. By using IMS in tandem with MS, six fold increase in the peak capacity was observed (~19000) compared to peak capacity of the MS as a standalone method of separation (~3000).
Conclusions
The high resolution ion mobility mass spectrometer used in this study provided an average IMS resolving power of ~ 90 and MS resolution of ~1500. Reproducible reduced mobility values for metabolites in milli-molar to nano-molar concentration range can be achieved. Without any pre-concentration, over 1100 metabolites can be detected in methanol extracts of 50 µL of blood samples. Along with the detection of metabolites in the blood extract, simultaneous separation of over 300 isomeric/isobaric metabolites can also be accomplished. Various classes of metabolites including amino acids, carbohydrates, endogenous amines, purines and pyrimidines, organic acids, sterols, estrogens, prostaglandins, phosphocholines, mono-and di-acylglycerophosphoethanolamines, mono-and di-acylglycerols, sphingolipids, isoprenoids and various metabolic intermediates can be concurrently detected and separated in a 2D IM-MS analysis. Peak capacity of mass spectrometers can be increased by a factor of six by coupling of IMS as a pre-separation technique prior to MS analysis which can be further increased by increasing the separation power of IMS and MS.
An important advantage of IM-MS is separation of similar classes of metabolites along a unique MMC lines that can be used to complement and facilitate identification of metabolites detected by MS. Two dimensional IM-MS analysis facilitates separation of random noise peaks from low intensity metabolite peaks through differentiation in mobility space and thus make possible detection of low abundance metabolites.
When compared to LC-MS when applied to blood metabolite detection, IM-MS even with limited orthogonality in separation, demonstrated detection of comparable number of metabolic features in the blood metabolome due to high resolving power of the IMS. Ion mobility mass spectrometry with its ability to rapidly provide high resolution comprehensive complex sample analyses and its compatibility with various analytical methods such as chromatography appears to be a promising new analytical technique for assessment of metabolomes. Further improvement in IM-MS separation power and ion transmission efficiency would significantly enhance the potential of IM-MS as applied to metabolomics studies. Development of IM-MS spectral databases and multidimensional instrumentation and data processing software would allow rapid metabolome analysis and interpretation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Schematic of the electrospray ionization atmospheric pressure ion mobility time of-flight mass spectrometer used for the analysis of human blood metabolome. This instrument is comprised of nine primary units: (1) electrospray ionization source; (2) heated atmospheric pressure desolvation region; (3) Bradbury-Nielsen ion gate; (4) counter-flow atmospheric pressure drift region; (5) differentially pumped interface; (6) ion guide with ion lenses; (7) extraction region; (8) reflectron time-of-flight mass analyzer, (9) bipolar MCP detector and (10) time to digital converter for data acquisition. 2D IMMS spectrum of an equimolar (500 n Molar) metabolite mixture solution containing serine, nicotinamide, adenine, lysine, glutamine, ribose, phenylalanine, arginine, glucose, lactose, and maltose in 50:50 MeOH and H 2 O with 1% acetic acid and 30 minute data acquisition time is shown. All metabolites in the mixture were detected as one or more than one of the following adducts: {M (H 2 O)n + H} + , {M (MeOH)n + H} + , {M (H 2 O)n + Na} + (Table 1 ). One dimensional mass spectrum (1) compared to one dimensional mass spectrum with mobility differentiation (2) . Three main features observed: a) noise peak accounted as real peak (bold line), b) contribution of random noise to peak intensity (dashed line), and c) real peak lost in noise (dotted line). A: MMCC for amino acids detected in the blood extract. Peaks identified as amino acids in blood extract based on mass and reduced mobility data matched with that measured for standard solutions of amino acids. B: MMCC for various classes of metabolites detected in the blood sample. Only protonated ions of metabolites constitute the MMCC (except for the sugars as sodium adducts). Two dimensional space (shaded area in the X-Y quadrant) occupied by metabolites that were detected in human blood extract by ESI-IM-MS (Peak capacity) is illustrated. The theoretical MMCC (dotted line) is the centre line of the shaded area along which a constant drift time deviation should be observed. MMCC for the experimental data is depicted as bold line. The length of the 2D space is defined by the m/z range and width is defined by the maximum and minimum drift time deviation observed at a particular m/z value shown as double sided in the figure.
